l e t t e r s
Although membrane proteins are ubiquitous within all living organisms and represent the majority of drug targets, a general method for direct, label-free measurement of ligand binding to native membranes has not been reported. Here we show that backscattering interferometry (BSI) can accurately quantify ligand-receptor binding affinities in a variety of membrane environments. By detecting minute changes in the refractive index of a solution, BSI allows binding interactions of proteins with their ligands to be measured at picomolar concentrations. Equilibrium binding constants in the micromolar to picomolar range were obtained for small-and large-molecule interactions in both synthetic and cell-derived membranes without the use of labels or supporting substrates. The simple and low-cost hardware, high sensitivity and label-free nature of BSI should make it readily applicable to the study of many membraneassociated proteins of biochemical and pharmacological interest.
Cellular membranes are complex two-dimensional fluid structures composed of stringently regulated combinations of lipids and proteins. Many critical cellular processes are triggered through the transduction of binding-dependent molecular signals across the membrane 1 . Membrane-associated proteins and their interactions are therefore of paramount interest for drug discovery and development, accounting for almost 70% of existing drug targets 2 . Although many assays exist to examine this class of molecular interactions, targets of interest are typically removed from the native membrane environment or undergo substantial modification before observation. Often the membrane protein is truncated or functionalized by genetic modification in an attempt to engineer experimental compatibility with investigative techniques that rely primarily on either covalent labeling or surface coupling strategies. Such modifications can affect a target's function in unpredictable ways and are not uniformly applicable in all systems 3 .
We have recently found BSI to be sensitive to the minute changes in refractive index of a solution or surface that occur when dissolved or adsorbed molecular agents bind analytes [4] [5] [6] [7] . By introducing a sample into a microfluidic device properly configured to create a resonance cavity and a long, effective path length, incident coherent light is converted into an interferometric fringe pattern that can be captured on a standard CCD camera (Fig. 1a) . Fourier analysis of this fringe pattern reports on very small changes in refractive index that can be correlated in real time with receptor-ligand interactions occurring in solution or with species tethered to the microfluidic channel surface without the use of contrast-enhancing label molecules of any kind. We describe here the extension of this methodology to several species of membrane proteins in lipid membranes of varying heterogeneity, in an attempt to mirror more closely the relevant functionality of biological molecules in their native environment.
In the simplest case, binding interactions of integral membrane components were examined using fully synthetic membrane components, allowing for a well-defined display of the desired ligands within the context of a fluid lipid bilayer. For this example, the monosialoganglioside GM1 was combined with phosphatidylcholine and phosphatidylserine to form small, unilamellar vesicles (SUVs; Fig. 1b ) averaging 40 ± 3 nm in diameter, as determined by dynamic light scattering. GM1 is implicated in a variety of neurological developmental processes and diseases 8 and is the primary lipid component to which cholera-and related toxins bind to gain entry into the cell 9 . Separate samples of the GM1-containing vesicles were incubated with varying concentrations of the cholera toxin B subunit to reach equilibrium. These solutions were compared by BSI to mixtures lacking the GM1 ligand but of otherwise identical composition. The observed change in refractive index, manifested as a shift in phase of the interference fringe pattern, was plotted against the concentration of added analyte. The result was a sigmoidal curve that fit well to a simple, single-site binding model (Fig. 2a) , yielding an equilibrium binding constant of 129 ± 27 pM. This value is between the published determinations of 4.6 pM (surface plasmon resonance measurements on immobilized GM1; ref. 10) and 20 nM (fluorescence microscopy on supported lipid bilayers 11 ) and represents conditions that are much closer to the natural environment of this interaction than either of the previously described experiments. As a negative control, the same GM1-containing vesicles were treated with full-length tetanus toxin, which binds membrane receptors other than GM1 (Fig. 2a) . Little or no signal was observed in these experiments, showing that the BSI signal reflected the specific GM1-cholera toxin B interaction rather than a nonspecific association with the membrane, and that sub-nM binding affinity can be determined in free solution with this technique.
In the above study, a uniformly distributed small-molecule ligand (GM1) was incorporated into the membrane, which was then bound by a soluble protein (cholera toxin B). More generally useful, however, is quantification of the binding of soluble ligands to membrane proteins.
Using detergent solubilization and dialysis, it is relatively straightforward to incorporate labile, functional membrane proteins, from both natural and recombinant sources, into synthetic membranes to form proteoliposomes. Binding measurements are most commonly made on proteoliposomes in free solution with fluorescence spectroscopy or by radioligand displacement, both of which require labeling of one or more binding partners. Other techniques such as total internal reflection fluorescence microscopy and atomic force microscopy, though highly sensitive, require a supported lipid bilayer to allow compatibility with the optical geometries involved 12 . In supported membranes, transmembrane proteins usually suffer from restricted movement, presumably due to interactions with the underlying surface 13, 14 . It is also common to truncate such proteins, attaching a membranecompatible insertion tag such as a glycosylphosphatidylinositol anchor to allow free lateral diffusion within the membrane leaflet. As BSI is capable of detecting binding events on free vesicles in solution, we postulated that such modifications would be unnecessary.
We examined three integral membrane proteins to test this hypothesis: fatty acid amide hydrolase (FAAH), the CXCR4 receptor and the GABA B receptor. FAAH is a membrane protein important in neurological function and a drug target for pain management and other indications 15, 16 . Purified FAAH was incorporated into synthetic SUVs in the manner described above for GM1. Upon treatment of these vesicles with several small-molecule inhibitors, dose-dependent signals were observed by BSI (Fig. 2b-d and Table 1 l e t t e r s from the K i values reported for these reversible covalent inhibitors 17 (4.7 nM and 20 nM, respectively 18, 19 ). The closely related analog JG-II-145, a less potent inhibitor of FAAH by more than three orders of magnitude 20 , gave a correspondingly weakened K d of 4.1 ± 1.7 µM ( Table 1) , illustrating the dynamic range of the BSI assay to be at least several logs. When performed at the same pH used for the reported enzyme inhibition assay (pH 9.0) [17] [18] [19] [20] , BSI measurements showed somewhat tighter binding of the inhibitors and again mirrored the relative differences between observed K i values ( Fig. 2 and Table 1) . No BSI signals were obtained under either set of conditions when the same FAAH-containing vesicles were treated with high concentrations of cholesterol, which is likely to be incorporated into the lipid bilayer when introduced to the solution. Taken together, the data indicate that it is a specific binding event rather than a change induced by the nonspecific interaction of hydrophobic molecules with lipid bilayers that is detected by BSI.
The mismatch in absolute values between the K d values observed here for the FAAH inhibitors and K i values reported in the literature is likely to reflect the fundamentally different nature of these parameters, especially for this type of system in which inhibition is the result of both a binding step and a covalent capture step in the enzyme active site 21 . Although direct comparisons are rare, other examples of differences in binding constant and inhibitory activity of similar magnitudes have been described (see Supplementary Methods). That no values of binding affinities of antagonists of FAAH and many other important enzymes have been published shows how much more difficult it is to make such measurements than it is to measure the effects of inhibitors on enzyme function.
It is especially troublesome to perform direct, label-free measurements of binding to proteins in native membranes, although such data would be the most relevant to in vivo considerations. Ligand binding events have therefore typically been inferred from cellular responses in whole cells or with the use of radioactive assays on cell lysates. Because the refractive index changes detected by BSI should not be affected by the presence of noninteracting species in the mixture, we tested the ability of BSI to detect binding events in native cell extracts. To provide the required type of isotropic matrix that scatters little light which is still suitable for BSI analysis, we separated the outer membranes of cultured cells from their intracellular components and converted the membranes into vesicle-like suspensions of uniform size.
We chose two representative targets for this study. The CXCR4-CXCL12 system represents a receptor-chemokine pair of great fundamental and applied interest in cell biology and medicine 22 . Using a variation of existing methods for the preparation of red blood cell 'ghosts' , human SUP-T1 lymphoma T cells expressing the CXCR4 receptor were subjected to hypotonic lysis, sonication and purification to produce outer membrane-derived vesicles ( Supplementary  Fig. 2 ) with an approximate diameter of 180 ± 20 nm, measured by dynamic light scattering. It is assumed that these vesicles display the cell's associated membrane proteins in a manner closely analogous to their native environment. The vesicle preparations were interrogated with increasing concentrations of the soluble chemokine CXCL12 to derive the binding curve shown in Figure 2h and a K d value (0.7 nM) very similar to the reported value for 50% saturation of the receptor (1.8 nM; Table 1 ). SUP-T1 cells with the CXCR4 receptor knocked out showed no interaction with added CXCL12 (data not shown), illustrating the specificity of the BSI detection of the binding event amid a variety of other membrane-bound components.
The heterodimeric 23 γ-aminobutyric acid (GABA) receptor represents an even more complex target 24 . This G protein-coupled receptor is implicated in many neurological disease phenotypes and is difficult to isolate and purify. Outer membrane-derived vesicles from Chinese hamster ovary (CHO) cells, genetically modified to overexpress the B(1b) and B2 components of the GABA B receptor, were prepared as above. The presence of the GABA B receptor in these lysisderived vesicles was verified by western blot analysis ( Supplementary  Fig. 3 ). The receptor ligand (GABA), two agonists (baclofen 25 and SKF-97541 (refs. 26,27) ) and one antagonist (CGP-54626, ref. 28) all gave BSI binding curves, in contrast to the negative control compounds (l-alanine and cholesterol) (Fig. 2i-l) . Again, the K d values obtained in these experiments agreed well with previously reported values, which were derived from radioligand displacement and competitive binding assays using membrane fractions from similar cells ( Table 1) . Although it did not compromise the overall accuracy of the measured values, the error bars for BSI measurements on the native membrane-derived samples were larger than for vesicles incorporating purified proteins, presumably caused by sample heterogeneity and nonspecific adsorption to the channel walls.
Backscattering interferometry is essentially a detector of differences in molecular structures, with binding measurements relying on the comparison of signals between free and bound states. Modeling of the BSI phenomenon (data not shown) indicates that much of the signal derives from changes in conformation and solvation that occur when a molecule such as a protein interacts with a ligand. It may be difficult to detect the replacement of one ligand by another using BSI if the bound structures have very similar levels of hydration and/or radii of gyration. Therefore, direct measurements of competitive binding are potentially more challenging with BSI than are individual measurements of binding affinities for ligands being compared.
In any event, BSI is shown here to provide direct and quantitative insight into binding events involving integral membrane proteins and membrane-bound species: to our knowledge no other labelfree, solution-phase technique is as generally and straightforwardly These studies were performed in endpoint mode, wherein liposome samples and ligands were mixed at the desired concentrations and measurements were made after equilibrium was reached, but realtime measurements should be feasible, as they have been performed previously on aqueous-soluble systems 6, 29 . The need to isolate the membrane-bound protein of interest often requires assays to be done in the presence of significant quantities of organic solvents, in detergent micelles or in other non-native environments. The BSI-based methodology provides data that are more relevant to the true binding abilities of the membrane-bound species of interest, without the need for protein alteration or, in some cases, isolation and is therefore likely to be of value in drug discovery, biochemistry and related fields.
METHodS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
oNLINE METHodS . Two different lines of suspension human T-lymphocytes (SUP-T1) cells were also used; one wild-type (CXCR4-positive) and one engineered to express a zinc-finger nuclease (CXCR4-negative). Both wild-type and engineered cells were kindly provided by Bruce Torbett (The Scripps Research Institute). Adherent cells were grown at 37 °C and 5% ambient CO 2 to near 100% confluence over 3 d from initial addition to 175 cm 2 -area flasks. Adherent cells were harvested by removing all growth medium from the flask and incubating with 4 ml of Detachin solution for 5 min at 37 °C. Incubation buffer (48 ml) was then added to the flask and the contents removed and transferred to two 50 ml centrifuge tubes. Suspension cells were grown to an approximate concentration of 300,000 cells/ml. In both cases, the cells and media were centrifuged for 5 min at 300g to pellet the cells. After centrifugation, the media was removed from the centrifuge tubes, the cells were resuspended in 1× PBS and the cell/PBS suspension recentrifuged. Cell pellets were rinsed three times in 1× PBS and used immediately. The expression of the GABA B receptor in membranes derived from the b12.2 cells was verified by western immunoblot analysis (Supplementary Fig. 3 ).
Native membrane vesicles. A cell pellet containing ~10 6 cells of either type was resuspended in 20 ml of ice-cold lysis buffer (2.5 mM NaCl, 1 mM Tris, 1× EDTA-free, broad-spectrum protease inhibitors, pH 8.0) and placed on a rotator for 45 min at 4 °C. The resulting solution was then centrifuged at 40,000g for 60 min at 4 °C. The supernatant was removed and resuspended in 4 ml of ice-cold 1× PBS and transferred to a 5 ml glass dram vial. The pellet and buffer were then probe-sonicated to clarity in an ice bath and transferred to a 220 nm Millipore Ultrafree-MC centrifuge tube filter. The resulting solutions were centrifuged for 1 h at 16,000g and 4 °C. All solution that passed through the centrifuge tube filter was collected and stored at 4 °C for up to 2 d. Sizes of both synthetic and native membrane vesicles was determined using a Wyatt Technologies DynaPro dynamic light scattering apparatus.
BSI instrumentation 6, 32 . BSI utilizes a red helium-neon (HeNe) laser (λ = 632.8 nm) to illuminate the microfluidic channel in a simple optical train. The laser is coupled to a collimating lens through a single-mode fiber, producing a 100 µm diameter beam and yielding probe volumes in the 300 picoliter range. When the laser beam intersects the fluid contained in the channel, a set of high-contrast interference fringes is produced, the spatial position of which depends on the refractive index (RI) of the fluid within the channel. The fringes were monitored in the direct backscatter region at relatively shallow angles (typically <7°) using a Garry 3000 linear array CCD camera (Ames Photonics). The camera was positioned so that the centroid of the interference pattern was located just above the lens on the end of the single-mode optical fiber to ensure that the alignment was along a central plane. Under these conditions the fringe pattern contains a dominant Fourier frequency; the phase of this dominant frequency is the BSI fringe shift signal, in radians 16 . BSI chips were isotropically etched in borosilicate glass to give a crosssection described by two quarter-circles of 40 µm radius connected by a 10 µm flat region, manufactured by Micronit. For BSI measurements, the chip was maintained in the instrument at 25 °C using a feedback-controlled peltier system. Very little sample is required: 1 µl of solution (~5 µM in protein) is introduced into the microfluidic channel for each measurement, of which 290 picoliters are interrogated by the laser. Five 1-µl aliquots containing different amounts of ligand were used to generate a complete binding curve, requiring a total of ~20 pmoles of protein.
Detection of ligand binding. Ligand binding to the SUVs was accomplished by incubating a fixed amount of SUV suspension with varying concentrations of ligands (bacterial toxins, FAAH ligands, GABA B modulators) for 8 h in the dark at 4 °C. Such a long incubation period is not necessary, and was done here only for experimental convenience and to ensure that equilibrium had been reached at the cold temperature, which slows membrane fluidity significantly. Channels used with synthetic membrane systems were pre-treated by incubating with a solution of non-ligand-containing SUVs followed by extensive rinsing with Milli-Q deionized (18.2 MW-cm) water. Channels used with cell-derived SUVs received no pre-treatment; the signal-to-noise ratio for all experiments showed no change for either pre-treatment condition. The chip surfaces were regenerated between uses by brief (5 min) incubation with sulfuric acid followed by extensive rinsing with Milli-Q deionized (18.2 MW-cm) water.
For each sample, a solution of SUVs and the 'control' ligand was introduced into the channel and the BSI signal was measured for 15 s. The channel was rinsed and the mixture of SUV and ligand of interest was introduced into the channel and the signal measured, and this procedure was repeated iteratively for increasing ligand concentrations. The binding signal was calculated as the difference in phase between the control SUV-ligand solution and the analyte SUV-ligand complex. The background signal due to the presence of the SUVs was subtracted from all measurements. This corrected binding signal was then plotted versus concentration to form a saturation binding curve and fitted to a square hyperbolic function to calculate the affinity.
Although we did not explore the detection limits for membrane-bound protein receptors, we note that the signal intensities observed here are very similar to those observed for soluble proteins in buffer. We therefore suspect that binding events to membrane-bound molecules will be detectable by BSI to very low concentrations because binding to solution-phase proteins has been characterized down to picomolar concentrations and proteins bound in a monolayer to the microfluidic channel are similarly detectable [4] [5] [6] [7] 33 . 
